感染新冠后可能各种疾病不断，轻症也不例外
疲劳、脑雾、味觉和嗅觉失灵。
大量证据显示，新冠之后诸多小病会长期缠身，而且这类疾病的种类似乎是越来越多。
如今，科学家又将血栓纳入了清单，而且一些血栓异常严重，会导致死亡。一份10月24日发布的最新报告显示，即便是新冠轻症患者也会在感染数周后出现风险。
在英国医疗周刊《Heart》上发布的一则基于伦敦的调查核查了近2万名英国新冠感染居民的病例，并与那些未感染者的病例进行了比较。
研究人员发现，与未患有新冠肺炎的个人相比，那些被诊断患有新冠肺炎但并未住院的个人患静脉血栓栓塞（静脉栓塞包括深静脉栓塞和肺栓塞）的风险会高出3倍。
研究人员发现，这类人员死亡的概率要高出10倍。作者写道：“有鉴于较大的新冠感染人群基数，这项报告可能预示着迫在眉睫的重大公共健康问题。”
研究发现，因新冠感染而住院的患者面临着更大范围的不良反应，以及血栓概率的增加。与未感染新冠病毒的人士相比，这些人患静脉血栓栓塞的风险高出近28倍，患心力衰竭的风险高出近22倍，患中风的风险高出近18倍。
作者称，研究中提到的大多数不良反应都是在感染后30天内发生，但“在患病很长一段时间后，风险依然有所增加。”
研究人员核查了英国前两轮新冠肺炎患者的病例。作者写道，我们需要开展进一步的研究来确定血栓和其他不良心血管反应的高风险会持续多长时间，并确定可以通过哪些方式来帮助存在这种不良反应的高风险病患。
人们认为，只要得到确诊，新冠就会推高血栓和相关问题的风险，这些问题包括心脏病和中风，然而，至于升级后的风险会持续多久依然没有定论。
9月在美国心脏协会（American Heart Association）的《循环杂志》发表的一项研究发现，与未感染新冠的人群相比，新冠肺炎患者出现深静脉血栓的风险几乎会翻倍。该研究还发现，升高后的深静脉血栓和动脉血栓风险在感染近一年之后依然存在。该研究核查了以匿名形式搜集的几乎所有英格兰和威尔士成年人的数据。（财富中文网）
译者：冯丰
审校：夏林
疲劳、脑雾、味觉和嗅觉失灵。
大量证据显示，新冠之后诸多小病会长期缠身，而且这类疾病的种类似乎是越来越多。
如今，科学家又将血栓纳入了清单，而且一些血栓异常严重，会导致死亡。一份10月24日发布的最新报告显示，即便是新冠轻症患者也会在感染数周后出现风险。
在英国医疗周刊《Heart》上发布的一则基于伦敦的调查核查了近2万名英国新冠感染居民的病例，并与那些未感染者的病例进行了比较。
研究人员发现，与未患有新冠肺炎的个人相比，那些被诊断患有新冠肺炎但并未住院的个人患静脉血栓栓塞（静脉栓塞包括深静脉栓塞和肺栓塞）的风险会高出3倍。
研究人员发现，这类人员死亡的概率要高出10倍。作者写道：“有鉴于较大的新冠感染人群基数，这项报告可能预示着迫在眉睫的重大公共健康问题。”
研究发现，因新冠感染而住院的患者面临着更大范围的不良反应，以及血栓概率的增加。与未感染新冠病毒的人士相比，这些人患静脉血栓栓塞的风险高出近28倍，患心力衰竭的风险高出近22倍，患中风的风险高出近18倍。
作者称，研究中提到的大多数不良反应都是在感染后30天内发生，但“在患病很长一段时间后，风险依然有所增加。”
研究人员核查了英国前两轮新冠肺炎患者的病例。作者写道，我们需要开展进一步的研究来确定血栓和其他不良心血管反应的高风险会持续多长时间，并确定可以通过哪些方式来帮助存在这种不良反应的高风险病患。
人们认为，只要得到确诊，新冠就会推高血栓和相关问题的风险，这些问题包括心脏病和中风，然而，至于升级后的风险会持续多久依然没有定论。
9月在美国心脏协会（American Heart Association）的《循环杂志》发表的一项研究发现，与未感染新冠的人群相比，新冠肺炎患者出现深静脉血栓的风险几乎会翻倍。该研究还发现，升高后的深静脉血栓和动脉血栓风险在感染近一年之后依然存在。该研究核查了以匿名形式搜集的几乎所有英格兰和威尔士成年人的数据。（财富中文网）
译者：冯丰
审校：夏林
Loss of taste and smell. Fatigue. Brain fog.
Ailments that can linger long after COVID have been well documented, and the list appears to be lengthening.
Now scientists are adding blood clots to the list, some so severe that they lead to death. Even a mild case of COVID can put one at risk in the weeks following infection, according to a new report released Monday.
The London-based study, published in British medical journal Heart, examined the records of nearly 20,000 U.K. residents who had experienced COVID, and compared them with those of similar individuals who had not.
Researchers found that individuals who had been diagnosed with COVID but weren’t hospitalized were still at a risk nearly three times as high for venous thromboembolism—blood clots in veins that can include deep vein thrombosis and pulmonary embolism—when compared with similar individuals who hadn’t had COVID.
Such individuals were more than 10 times as likely to experience death, researchers found.
“Given the high population exposure to COVID-19, these reports may herald a significant imminent public health problem,” the authors wrote.
A wider range of adverse events, and a greater incidence of them, was found among those who had been hospitalized with COVID. Such individuals were at a nearly 28-fold greater risk for venous thromboembolism, a nearly 22-fold greater risk for heart failure, and a nearly 18-fold greater risk for stroke, when compared with peers who hadn’t experienced COVID.
Most adverse events noted in the study occurred within 30 days of infection, but “the risk remains augmented for a prolonged period thereafter,” according to the authors.
The study examined records of patients during the first two waves of COVID in the United Kingdom. Further study is needed to determine how long the heightened risk for blood clots and other adverse cardiovascular events lasts, and to determine what might be done to help patients at high risk for such events, the authors wrote.
COVID is known to be linked to an increased risk of blood clots and related issues, including heart attack and stroke, immediately after diagnosis. But just how long that elevated risk lasts is unknown.
A September study published in the American Heart Association journal Circulation found that the risk of deep vein thrombosis was nearly double in those who had experienced COVID when compared with those who had not. It also found that an elevated risk of deep vein thrombosis and arterial thrombosis persisted for nearly a year after infection. It examined the anonymously collected data of nearly every adult in England and Wales.
